Aarti Drugs Ltd Share Price ₹372 | P/E 17.2

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Aarti Drugs Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	742	661	642	606	620	555	598	557	677	591	653	602	720
Expenses +	649	577	565	536	534	490	531	495	583	516	569	547	624
Operating Profit	94	84	76	70	86	65	67	62	93	74	84	55	96
OPM %	13%	13%	12%	12%	14%	12%	11%	11%	14%	13%	13%	9%	13%
Other Income +	1	1	1	2	1	1	1	12	2	0	0	1	1
Interest	9	9	8	8	9	9	9	9	9	9	8	9	8
Depreciation	12	13	13	13	14	13	14	14	15	15	16	18	18
Profit before tax	73	64	56	52	64	44	46	51	71	51	60	29	70
Tax %	23%	24%	30%	29%	26%	24%	24%	27%	12%	-6%	25%	-40%	21%
Net Profit +	56	48	40	37	47	33	35	37	63	54	45	41	55
EPS in Rs	6.06	5.17	4.31	3.99	5.15	3.62	3.84	4.06	6.89	5.91	4.96	4.44	6.05

Financials of Aarti Drugs Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	1,097	1,140	1,195	1,244	1,561	1,806	2,155	2,489	2,716	2,529	2,387	2,565
Expenses +	925	960	1,005	1,042	1,350	1,541	1,714	2,156	2,407	2,208	2,097	2,256
Operating Profit	172	180	190	202	211	266	440	333	309	321	290	309
OPM %	16%	16%	16%	16%	14%	15%	20%	13%	11%	13%	12%	12%
Other Income +	1	0	4	1	6	6	5	11	2	4	16	2
Interest	42	48	40	38	44	37	26	24	37	38	39	34
Depreciation	31	37	38	40	43	49	50	50	50	51	56	67
Profit before tax	100	95	116	125	131	185	369	270	224	236	212	211
Tax %	23%	28%	29%	34%	32%	24%	24%	24%	26%	27%	21%	8%
Net Profit +	77	69	82	82	90	141	280	205	166	172	168	195
EPS in Rs	7.97	7.09	8.57	8.73	9.52	15.17	30.09	22.14	17.96	18.65	18.42	21.36
Dividend Payout %	41%	24%	3%	3%	3%	3%	8%	5%	6%	5%	5%	0%

Financials of Aarti Drugs Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	24	24	24	24	24	23	93	93	93	92	91	91
Reserves	284	333	376	432	520	629	820	944	1,100	1,190	1,278	1,458
Borrowings +	448	483	480	546	507	389	351	543	609	564	615	577
Other Liabilities +	248	261	311	388	405	535	502	629	620	587	591	690
Total Liabilities	1,004	1,102	1,191	1,389	1,455	1,576	1,766	2,208	2,421	2,432	2,575	2,815
Fixed Assets +	448	493	581	602	625	644	665	690	676	811	866	1,086
CWIP	16	34	14	28	33	12	19	77	210	261	330	214
Investments	5	5	12	11	12	13	17	19	19	20	22	27
Other Assets +	534	570	584	748	785	907	1,064	1,422	1,516	1,340	1,356	1,488
Total Assets	1,004	1,102	1,191	1,389	1,455	1,576	1,766	2,208	2,421	2,432	2,575	2,815

Financials of Aarti Drugs Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	105	133	175	70	143	251	155	70	133	359	245	254
Cash from Investing Activity +	-107	-99	-107	-74	-62	-33	-72	-150	-164	-224	-165	-173
Cash from Financing Activity +	1	-33	-68	4	-80	-215	-81	92	17	-136	-82	-77
Net Cash Flow	-1	1	-0	0	1	2	2	13	-14	-1	-2	3
Free Cash Flow	-2	34	68	-5	80	214	78	-82	-31	133	67	80
CFO/OP	69%	85%	103%	47%	82%	110%	57%	46%	62%	131%	103%	81%

Financials of Aarti Drugs Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	105	106	91	110	107	99	94	110	116	102	115	118
Inventory Days	82	86	100	132	86	102	117	115	101	107	114	111
Days Payable	83	90	94	123	85	104	93	103	94	94	100	108
Cash Conversion Cycle	104	103	97	119	109	97	118	123	123	115	129	121
Working Capital Days	14	19	22	33	44	54	77	63	72	74	76	76
ROCE %		18%	18%	17%	17%	21%	34%	21%	15%	15%	13%	12%